14 results on '"Zheng, Wei Da"'
Search Results
2. The correlation between lung ultrasound scores and outcomes of high-flow nasal cannula therapy in infants with severe pneumonia
- Author
-
Zheng, Li-Ling, Chen, Rou, Zheng, Chan-Hua, Dai, Xiao-Juan, Zheng, Wei-Da, and Zhang, Jia-Xiang
- Published
- 2024
- Full Text
- View/download PDF
3. Enlargement of opisthenar microcirculatory area predicts impaired heart function in severe acute coronary syndrome patients
- Author
-
Chen, Chen, primary, Zhu, Bai Lin, additional, Zheng, Wei Da, additional, Guo, Zhen Yi, additional, Jin, Xin, additional, Zhao, Zai Hao, additional, Lin, Mei Hua, additional, Cui, Lan, additional, and Zhang, Yin Hua, additional
- Published
- 2023
- Full Text
- View/download PDF
4. Cidan Capsule in Combination with Adjuvant Transarterial Chemoembolization Reduces Recurrence Rate after Curative Resection of Hepatocellular Carcinoma: A Multicenter, Randomized Controlled Trial
- Author
-
Zheng, Dong-hai, primary, Yang, Jia-mei, additional, Wu, Jian-xiong, additional, Cheng, Shu-qun, additional, Zhang, Shao-geng, additional, Wu, Dong, additional, Li, Ai-jun, additional, Fu, Xiao-hui, additional, Li, Xun, additional, Qi, Fu-chen, additional, Duan, Wei-hong, additional, Chen, Jun-hui, additional, Yang, Zhi-ying, additional, Liang, Lu, additional, Zeng, Jin-xiong, additional, Zheng, Wei-da, additional, and Wu, Meng-chao, additional
- Published
- 2022
- Full Text
- View/download PDF
5. Interleukin-10 gene modification attenuates hepatocyte activation of rat hepatic stellate cells in vitro
- Author
-
CHEN, YUN-XIN, primary, HUANG, YUE-HONG, additional, ZHENG, WEI-DA, additional, CHEN, ZHI-XIN, additional, ZHANG, LI-JUAN, additional, and WANG, XIAO-ZHONG, additional
- Published
- 2012
- Full Text
- View/download PDF
6. Expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 in hepatic stellate cells during rat hepatic fibrosis and its intervention by IL-10
- Author
-
Zheng, Wei-Da, primary
- Published
- 2005
- Full Text
- View/download PDF
7. Interleukin-10 gene modification attenuates hepatocyte activation of rat hepatic stellate cells in vitro.
- Author
-
Chen YX, Huang YH, Zheng WD, Chen ZX, Zhang LJ, and Wang XZ
- Subjects
- Actins metabolism, Animals, Apoptosis, Cell Proliferation, Cells, Cultured, Coculture Techniques, Collagen Type I metabolism, Hepatocytes metabolism, Liposomes chemistry, Liposomes metabolism, Rats, Rats, Sprague-Dawley, Transfection, Hepatic Stellate Cells cytology, Hepatocytes cytology, Interleukin-10 genetics
- Abstract
Activation of hepatic stellate cells (HSCs) plays a key role in the progression of liver fibrosis. Interleukin-10 (IL-10), a potential anti-fibrosis cytokine, has an unfavorable pharmacokinetic profile, which limits its clinical applications. A liver-targeting gene delivery system may maintain a longer-lasting concentration in hepatic tissue with fewer side‑effects in non-target tissues. In the present study, when delivered by asialoglycoprotein receptor-mediated liposomes, the IL-10 gene was highly expressed in BRL cells (a rat hepatocyte line) and attenuated the apoptosis of BRL cells induced by plasmid transfection. In a co-culture system, BRL cells demonstrated a marked ability to stimulate the proliferation of primary HSCs and their expression of α-SMA and procollagen type I. Following modification of the BRL cells with the IL-10 gene, this stimulation was attenuated and an accelerated apoptosis of the HSCs was induced. These results suggest that hepatocyte‑targeting gene delivery may be an ideal technique for the IL-10 gene therapy of liver fibrosis, which requires further confirmation by in vivo studies.
- Published
- 2013
- Full Text
- View/download PDF
8. [The effect of IL-10 on proliferation of primary cultured hepatocytes].
- Author
-
Lin XP, Huang YH, Zheng WD, Chen YX, Chen ZX, and Wang XZ
- Subjects
- Animals, Cell Cycle drug effects, Cell Proliferation drug effects, Cells, Cultured, Hepatocytes metabolism, Insulin pharmacology, Interleukin-10 genetics, Interleukin-10 Receptor alpha Subunit genetics, Male, Rats, Rats, Sprague-Dawley, Reverse Transcriptase Polymerase Chain Reaction, Hepatocytes cytology, Hepatocytes drug effects, Interleukin-10 pharmacology
- Abstract
Aim: To investigate the effect of IL-10 on proliferation of rat primary cultured hepatocytes., Methods: Rat hepatocytes were isolated from rat liver by in situ digestion of collagenase IV and cryopreserved, resuscitated, cultured in vitro. Reverse-transcription polymerase chain reaction (RT-PCR) was used to characterize the purity of hepatocytes and analyze IL-10/IL10Ralpha mRNA from freshly isolated cells. The primary cultured hepatocytes were divided into 3 groups and treated with nothing (group N), Insulin (group C), and IL-10 in combination with Insulin (group I), respectively. Nuclear cell cycle analysis, MTT, and Trypan Blue cell count was assayed., Results: RT-PCR showed expression of characterization genes in primary hepatocytes group and liver tissue are different. RT-PCR showed an expression of IL-10/IL10Ralpha mRNA in rat primary hepatocytes. Trypan Blue cell count showed an depression of cell quantity in group I at 48h (71.96% contrast to group C, P<0.05). MTT analyse also showed absorbance of group I was declined contrast to group C at 24 h and 48 h (88.41% and 90.24%, P<0.05). Cell cycle analysis via FCM showed a decline at 24h in group I than group C and group N (59.06% and 70.18%, P<0.01)., Conclusion: The primary hepatocytes we isolated is quite purity. Rat primary hepatocytes express IL-10/IL10Ralpha mRNA. IL-10 has an suppression effect on proliferation of primary cultured hepatocytes.
- Published
- 2008
9. [Construction of eukaryotic expression plasmid containing rat interleukin-10 gene and its expression in BRL cells in vitro].
- Author
-
Chen YX, Huang YH, Chen ZX, Zheng WD, and Wang XZ
- Subjects
- Animals, Cell Line, Enzyme-Linked Immunosorbent Assay, Genetic Vectors chemistry, Hepatocytes metabolism, Interleukin-10 genetics, Liposomes chemistry, Plasmids, Polymerase Chain Reaction, Rats, Genetic Vectors genetics, Interleukin-10 metabolism, Transfection methods
- Abstract
Aim: To construct eukaryotic expression vector of rat IL-10 gene and observe its expression in hepatocyte cell line BRL., Methods: Total RNA was extracted from rat peripheral blood mononuclear cells. The full length coding region of IL-10 was amplified by RT- nested PCR and cloned into eukaryotic expression vector pcDNA3.0. The recombinant plasmid was transfected into BRL cells with either liposome Transfast or asialoglycoprotein receptor mediated liposome PEIjet-gal respectively. The expression of IL-10 mRNA was detected with PCR and that of IL-10 secreted from BRL cells transfected by liposome PEIjet-gal was detected with ELISA., Results: The recombinant plasmid was identified and confirmed with digestion of restriction endonuclease and DNA sequencing. Receptor mediated liposome PEIjet-gal exhibited significantly higher transfection efficiency than liposome Transfast and higher level secretory IL-10 expressed in BRL cells., Conclusion: The eukaryotic expression vector of IL-10 gene was successfully constructed. Asialoglycoprotein receptor-mediated liposome had high transfection efficiency on hepatocytes, suggesting that it could be a potential hepatocyte-targeting delivery system for IL-10 gene therapy.
- Published
- 2008
10. Antifibrotic effects of interleukin-10 on experimental hepatic fibrosis.
- Author
-
Zhang LJ, Zheng WD, Chen YX, Huang YH, Chen ZX, Zhang SJ, Shi MN, and Wang XZ
- Subjects
- Actins metabolism, Animals, Disease Models, Animal, Electrophoresis, Immunohistochemistry, Liver cytology, Male, Matrix Metalloproteinase 2 metabolism, NF-kappa B metabolism, Rats, Rats, Sprague-Dawley, Tissue Inhibitor of Metalloproteinase-1 metabolism, Transforming Growth Factor beta1 metabolism, Fibrinolysis physiology, Interleukin-10 physiology, Liver Cirrhosis, Experimental metabolism
- Abstract
Background/aims: To study the effects of interleukin-10 on hepatic stellate cells and liver tissue in experimental rats hepatic fibrosis., Methodology: Rat hepatic fibrosis model induced by carbon tetrachloride was established. Liver tissues were harvested from the rats administered CCl4 with or without IL-10 treatment and the animals of the control group. The expression of TGF-beta1, MMP-2 and TIMP-1 in the liver tissues was measured by S-P immunohistochemistry. In addition, another model was established; HSCs in rats in each group were isolated. RT-PCR was employed to analyze TGF-beta1, MMP-2 and TIMP-1 mRNA expression in cells and immunocytochemistry was performed to detect protein expression of alpha-SMA, NF-kappaB, TGF-beta1, MMP-2 and TIMP-1 in HSCs., Results: Rat hepatic fibrosis was developed successfully. The fibrosis changes were partially reversed by simultaneous administration of IL-10. The positive signals of TGF-beta1, MMP-2 and TIMP-1 were observed more frequently (P<0.05) in the CCl4-treated group compared to those in the IL-10-treated group and the control group. HSCs were successfully isolated. TGF-beta1, MMP-2 and TIMP-1 mRNA in HSCs increased obviously during the course of hepatic fibrosis, and their levels were decreased after the treatment with IL-10 (P<0.05). The immunocytochemistry positive levels for TGF-beta1, MMP-2, TIMP-1, alpha-SMA and NF-kappaB in the fibrogenesis group were increased significantly compared to the normal group (P<0.01). The positive signals decreased significantly (P<0.05) after the treatment with IL-10., Conclusions: The expression of TGF-beta1, MMP-2 and TIMP-1 increased in liver or in HSC of hepatic fibrosis rats and decreased after treatment with IL-10. The IL-10 could inhibit the activation of HSCs and make an antifibrogenic process come into effect in this way.
- Published
- 2007
11. Relationship between transforming growth factor beta1 and anti-fibrotic effect of interleukin-10.
- Author
-
Shi MN, Huang YH, Zheng WD, Zhang LJ, Chen ZX, and Wang XZ
- Subjects
- Animals, Base Sequence, Carbon Tetrachloride toxicity, Gene Expression drug effects, Immunohistochemistry, Liver Cirrhosis chemically induced, Liver Cirrhosis genetics, Liver Cirrhosis metabolism, Male, RNA, Messenger genetics, RNA, Messenger metabolism, Rats, Rats, Sprague-Dawley, Transforming Growth Factor beta genetics, Transforming Growth Factor beta1, Interleukin-10 pharmacology, Liver Cirrhosis drug therapy, Transforming Growth Factor beta metabolism
- Abstract
Aim: To study the effect of interleukin-10 (IL-10) on the expression of transforming growth factor beta1 (TGF-beta1) in hepatic fibrosis rats and the anti-fibrotic role of exogenous IL-10., Methods: Hepatic fibrosis was induced by carbon tetrachloride administered (CCl(4)) intraperitoneally. The experiment was performed in two stages. In the first stage, 60 SD rats were divided randomly into normal control group 1 (GN(1), n=8), hepatic fibrosis group (GC, n=28)and IL-10 intervened group (GI, n=24). At the beginning of the 7(th) and 11(th) wk, hepatic stellate cells (HSCs) were isolated, reverse transcription-polymerase chain reaction (RT-PCR) and immunocytochemistry were performed to detect the expression of TGF-beta1 in HSCs. Histological examination was used to determine the degree of hepatic fibrosis. In the second stage, 47 SD rats were divided randomly into normal control group 2 (GN(2), n=6)and CCl(4) group(GZ, n=41). At the end of the 9(th) wk, rats in GZ group were allocated randomly into model group(GM, n=9), IL-10 treatment group (GT, n=9)and recovered group (GR, n=9). At the end of the 12(th) wk, all rats were sacrificed. RT-PCR and immunohistochemistry were performed to detect the expression of TGF-beta1 in liver tissue. ELISA was used to assay serum TGF-beta1 levels., Results: Hepatic fibrosis developed in rats with the increase of the injection frequency of CCl(4). In the first stage, hepatic fibrosis developed and HSCs were isolated successfully. At the 7(th) and 11(th) wk, TGF-beta1 mRNA in GC group increased significantly compared with that in GN(1) (P=0.001/0.042) and GI groups (P=0.001/0.007), whereas there was no significant difference between the two groups. The levels of TGF-beta1 at the beginning of the 7(th) wk was higher than that of the 11(th) wk (P=0.049). Immunocytochemistry results of TGF-beta1 were consistent with the above findings. In the second stage, TGF-beta1 increased significantly in GM group compared to GN(2). After treatment with IL-10, TGF-beta1 declined obviously. The expression of TGF-beta1 decreased in GR group but was still higher than that in GT group., Conclusion: The levels of TGF-beta1 are increased in hepatic fibrosis rats and decreased after treatment with exogenous IL-10. IL-10 may play an anti-fibrotic role by suppressing TGF-beta1 expression.
- Published
- 2006
- Full Text
- View/download PDF
12. Effects of interleukin-10 on activation and apoptosis of hepatic stellate cells in fibrotic rat liver.
- Author
-
Zhang LJ, Zheng WD, Shi MN, and Wang XZ
- Subjects
- Actins analysis, Animals, Carbon Tetrachloride, Fas Ligand Protein, Liver Cirrhosis chemically induced, Liver Cirrhosis pathology, Male, Membrane Glycoproteins analysis, NF-kappa B analysis, RNA, Messenger analysis, Rats, Rats, Sprague-Dawley, Receptors, Tumor Necrosis Factor analysis, Signal Transduction, Tumor Necrosis Factors analysis, fas Receptor, Apoptosis drug effects, Interleukin-10 pharmacology, Liver drug effects, Liver Cirrhosis drug therapy
- Abstract
Aim: To study the effects of interleukin-10 (IL-10) on the expression of alpha-smooth muscle actin (alpha-SMA), nuclear factor- kappa B(NF- kappa B) and Fas/Fas ligand (FasL) in hepatic stellate cells of experimental rats with hepatic fibrosis., Methods: Sixty clean SD rats were randomly divided into control group (group N), liver fibrotic group (group C) and IL-10 treatment group (group I). Control group received intraperitoneal injection of saline (2 mL/kg), twice a week. Fibrotic group was injected intraperitoneally with 50% carbon tetrachloride (CCl(4)) (2 mL/kg), twice a week. IL-10 treatment group was given IL-10 at a dose of 4 microg/kg 20 minutes before CCl(4) administration from the third week. Hepatic stellate cells (HSCs) were isolated from these rats at the seventh and eleventh weeks during the course of liver fibrosis, respectively. The expression of alpha-SMA and NF- kappa B in HSCs was measured by S-P immunohistochemistry. The expression of Fas and FasL mRNA was measured by RT-PCR. Furthermore, liver tissues were harvested from three groups at the same time., Results: The CCl(4)- induced experimental rat hepatic fibrosis model was established successfully. The purity of extracted hepatic stellate cells was about 95% and the yield of hepatic stellate cells was 1.2-2.3 x 10(6)/g liver tissue averagely. The positive expression of alpha-SMA and NF- kappa B was 36.5% and 28.5% respectively in group N. The positive levels of alpha-SMA and NF- kappa B were increased significantly in group C compared to group N (P<0.01). The positive signals decreased significantly (P<0.05) in group I. In the 11th week, the HSCs of group I became round with visible pyknotic nuclei. The expression of NF- kappa B in group C was significantly increased in a time-dependent manner (P<0.01), but there was no difference in the alpha-SMA expression (P>0.05). The mRNA of Fas and FasL in group C was significantly increased in a time-dependent manner compared to that in control group. After treated with IL-10, the expression level of Fas and FasL was higher in group I than in group C., Conclusion: The positive expression of alpha-SMA and NF- kappa B in hepatic stellate cells is decreased by ectogenic IL-10 in liver fibrosis induced by CCl(4). The expression of Fas and FasL is increased in the course of liver fibrosis, and is further increased by IL-10. IL-10 could inhibit the activation of HSCs and cause apoptosis of activated HSCs.
- Published
- 2006
- Full Text
- View/download PDF
13. Therapeutic effect of interleukin-10 on CCl4-induced hepatic fibrosis in rats.
- Author
-
Huang YH, Shi MN, Zheng WD, Zhang LJ, Chen ZX, and Wang XZ
- Subjects
- Animals, Carbon Tetrachloride, Collagen Type I analysis, Collagen Type III analysis, Immunohistochemistry, Liver chemistry, Liver drug effects, Liver pathology, Liver Cirrhosis chemically induced, Liver Cirrhosis pathology, Male, Matrix Metalloproteinase 2 analysis, Rats, Rats, Sprague-Dawley, Tissue Inhibitor of Metalloproteinase-1 analysis, Tumor Necrosis Factor-alpha analysis, Interleukin-10 therapeutic use, Liver Cirrhosis drug therapy
- Abstract
Aim: To study the therapeutic effect of exogenous interleukin-10 on CCl4-induced hepatic fibrosis in rats and its possible mechanisms., Methods: Fourty-seven SD rats were randomly divided into control group (group N) and CCl4-induced hepatic fibrosis model group (group C). After CCl4 was given for 9 wk, the model group was divided into three groups. Rats in group M were put to death immediately,rats in group T were treated with IL-10 for another three wk and then put to death, rats in group R recovered after three weeks and were then killed. The degree of hepatic fibrosis was measured by HE staining and histological activity index (HAI). Histological activity index (HAI), change of collagen types I and III were measured by Picrosirius staining. The expression of TNF-alpha, MMP-2 and TIMP-1 in liver tissue was measured by S-P immunohistochemistry., Results: CCl4- induced experimental rat hepatic fibrosis model was established successfully. The degree of hepatic fibrosis was markedly lower in group T than in groups M and R, and there was no difference between the two groups. The expression of collagen types I and III was significantly suppressed in group T and was slightly suppressed in groups M and R. The positive levels of TNF-alpha, MMP-2 and TIMP-1 in group M increased significantly compared to those in group N (P<0.01). The positive signals decreased significantly in groups T and R (P<0.01),but positive score was significantly lower in group T than in group R (P<0.01)., Conclusion: Exogenous IL-10 can reverse CCl4-induced hepatic fibrosis in rats. IL-10 may exert its reversible effects on hepatic fibrosis by blocking CCl4-induced inflammation,inhibiting expression of MMP-2 and TIMP-1 and promoting resolution of collagen types I and III.
- Published
- 2006
- Full Text
- View/download PDF
14. Effect of IL-10 on the expression of HSC growth factors in hepatic fibrosis rat.
- Author
-
Shi MN, Zheng WD, Zhang LJ, Chen ZX, and Wang XZ
- Subjects
- Animals, Base Sequence, Carbon Tetrachloride Poisoning metabolism, DNA Primers, Gene Expression Regulation drug effects, Liver Diseases pathology, Male, RNA, Messenger genetics, Rats, Rats, Sprague-Dawley, Transforming Growth Factor beta1, Carbon Tetrachloride Poisoning pathology, Epidermal Growth Factor genetics, Hepatocyte Growth Factor genetics, Interleukin-10 pharmacology, Liver Diseases metabolism, Transforming Growth Factor beta genetics
- Abstract
Aim: To study the effect of IL-10 on the expression of growth factors--transforming growth factor-beta1 (TGF-beta1), epidermal growth factor (EGF), hepatocyte growth factor (HGF) and platelet-derived growth factor (PDGF) of hepatic stellate cells (HSCs) of hepatic fibrosis rat and the anti-fibrogenic role of exogenous IL-10., Methods: Hepatic fibrosis was induced by CCl(4) administration intra-peritoneally. Sixty clean male Sprague-Dawley (SD) rats were randomly divided into three groups: normal control group (GN, 8 rats), hepatic fibrosis model group (GC, 28 rats) and IL-10 treated group (GI, 24 rats). At the beginning of the 7th and 11th wk, rats in each group were routinely perfused with pronase E and type IV collagenase through a portal vein catheter and the suspension obtained from the liver was spun by centrifugation with 11% Nycodenz density gradient to isolate HSCs. Histological examination was used to determine the degree of hepatic fibrosis. RT-PCR was employed to analyze mRNA expression from freshly isolated cells. Immunocytochemistry was performed to detect protein expression in primary cultured HSCs., Results: Rat hepatic fibrosis was developed with the increase of injection frequency of CCl(4), and HSCs were successfully isolated. At the 7th and 11th wk, TGF-beta1, EGF, and HGF mRNA in GC increased obviously compared with GN (P = 0.001/0.042, 0.001/0.001, 0.001/0.001) and GI (P = 0.001/0.007, 0.002/0.001, 0.001/0.001). For TGF-beta1, no difference was observed between GI and GN. For EGF, mRNA level in GI increased compared with GN during the 7th wk (P = 0.005) and 11th wk (P = 0.049). For HGF, mRNA level in GI decreased compared with GN at the 7th wk (P = 0.001) and 11th wk (P = 0.021). Between these two time points, TGF-beta1 expression at the 7th wk was higher than that of the 11th wk (P = 0.049), but for EGF, the former was lower than the latter (P = 0.022). As for PDGF mRNA, there was no significant difference between these groups, but difference seemed to exist in protein levels. Results by immunocytochemistry of TGF-beta1 and EGF were paralleled with the above findings., Conclusion: The expression of TGF-beta1, EGF and HGF increased in HSC of hepatic fibrosis rat and decreased after treatment with IL-10. IL-10 plays an anti-fibrogenic role by suppressing growth factors expression.
- Published
- 2005
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.